Predictive value of IHC4 score for response to neoadjuvant chemotherapy in breast cancer

被引：0
|
作者：
Elsamany, S. [1 ]
Elmorsy, S. [2 ]
Alzahrani, A.
Rasmy, A. [3 ]
Abozeed, W. [4 ]
Mohammed, A. A. [5 ]
Ateia, M. [6 ]
Abbas, M. M. [7 ]
Mashhour, M. [8 ]
机构：
[1] Mansoura Univ, Med Oncol Oncol Ctr, Mansoura, Egypt
[2] Cairo Univ, Fac Med, Pharmacol, Cairo, Egypt
[3] King Fahed Specialist Hosp, Oncol, Dammam, Saudi Arabia
[4] Mansoura Univ Hosp, Mansoura, Egypt
[5] Fac Med, Med Oncol, Zagazig, Egypt
[6] Cairo Univ, Natl Canc Inst, Med Oncol, Cairo, Egypt
[7] King Abdullah Med City, Pathol, Mecca, Saudi Arabia
[8] King Fahed Specialist Hosp, Pathol, Dammam, Saudi Arabia
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70230-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P196
引用
收藏
页码：S91 / S92
页数：2
相关论文
共 50 条
  • [1] A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer
    Tan, Weige
    Luo, Wei
    Jia, Weijuan
    Liang, Gehao
    Xie, Xinhua
    Zheng, Wenbo
    Song, Erwei
    Su, Fengxi
    Gong, Chang
    [J]. ONCOTARGET, 2016, 7 (52) : 87312 - 87322
  • [2] Combined IHC4 score and local recurrence in breast cancer
    Lakhanpal, Roopa
    Shadbolt, Bruce
    Bennett, Genevieve M.
    Brown, Michael
    Phillips, Tessa
    Bullman, Amanda
    Rezo, Angela
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer
    Sheri, A.
    Smith, I. E.
    Hills, M.
    Jones, R. L.
    Johnston, S. R.
    Dowsett, M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (02) : 395 - 400
  • [4] Interobserver Agreement of Breast Cancer IHC4 after "Score the Core" Training
    Borowsky, Alexander
    Balassanian, Ronald
    Yau, Christina
    Engelberg, Jesse A.
    Thompson, Carlie K.
    Retallack, Hanna E. G.
    Bishop, John F. V.
    Cardiff, Robert
    Carpenter, Philip M.
    Chen, Yunn Yi
    Datnow, Brian
    Hasteh, Farnaz
    Krings, Gregor
    Lin, Fritz
    Zhang, Yanhong
    Lindstrom, Linda S.
    [J]. MODERN PATHOLOGY, 2016, 29 : 33A - 33A
  • [5] Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer
    A. Sheri
    I. E. Smith
    M. Hills
    R. L. Jones
    S. R. Johnston
    M. Dowsett
    [J]. Breast Cancer Research and Treatment, 2017, 164 : 395 - 400
  • [6] Prediction of response to neoadjuvant chemotherapy in estrogen receptor positive (ER plus ) breast cancer by IHC4 or Ki67 alone
    Sheri, A.
    Smith, I. E.
    A'Hern, R.
    Jones, R.
    Parton, M.
    Johnston, S. R. D.
    Dowsett, M.
    [J]. CANCER RESEARCH, 2013, 73
  • [7] Interobserver Agreement of Breast Cancer IHC4 after "Score the Core" Training
    Borowsky, Alexander
    Balassanian, Ronald
    Yau, Christina
    Engelberg, Jesse A.
    Thompson, Carlie K.
    Retallack, Hanna E. G.
    Bishop, John W.
    Cardiff, Robert
    Carpenter, Philip M.
    Chen, Yunn Yi
    Datnow, Brian
    Hasteh, Farnaz
    Krings, Gregor
    Lin, Fritz
    Zhang, Yanhong
    Lindstrom, Linda S.
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 33A - 33A
  • [8] IHC4 score plus clinical treatment score predicts locoregional recurrence in early breast cancer
    Lakhanpal, Roopa
    Sestak, Ivana
    Shadbolt, Bruce
    Bennett, Genevieve M.
    Brown, Michael
    Phillips, Tessa
    Zhang, Yanping
    Bullman, Amanda
    Rezo, Angela
    [J]. BREAST, 2016, 29 : 147 - 152
  • [9] Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy
    Fuksa, L.
    Micuda, S.
    Grim, J.
    Ryska, A.
    Hornychova, H.
    [J]. CANCER INVESTIGATION, 2012, 30 (09) : 663 - 678
  • [10] Quantitative Ki-67 score as predictive of response to neoadjuvant chemotherapy in breast cancer
    Brown, Jason R.
    Lannin, Donald R.
    Killelea, Brigid K.
    DiGiovanna, Michael
    Rimm, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345